Hazel Hunt - 26 Jan 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Hazel Hunt
Issuer symbol
CORT
Transactions as of
26 Jan 2022
Net transactions value
-$302,206
Form type
4
Filing time
28 Jan 2022, 16:53:57 UTC
Previous filing
16 Jul 2021
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $132,800 +40,000 +104% $3.32* 78,493 26 Jan 2022 Direct
transaction CORT Common Stock Tax liability $435,006 -25,350 -32% $17.16 53,143 26 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Options Exercise $0 -40,000 -100% $0.000000* 0 26 Jan 2022 Common Stock 40,000 $3.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 1, 2022.
F2 Fully exercisable.